The 5th edition of the World Health Organizat... - CLL Support
The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms released. Includes CLL/SLL
You need to be a member of this community to see this post.
Read more about...
- Blood tests
- Cancer and tumours
- Biopsy
- Menopause
- Clinical trials
- Chemotherapy
- Radioactive iodine
- Chlorambucil
- Cavernoma
- FCR
- Chronic leukaemia
6 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
"Accelerated" chronic lymphocytic leukemia/small lymphocytic lymphoma: unraveling CLL/SLL biological gray zone in the era of novel therapies
Encouraging news in this abstract from CLL/SLL researchers at the Northwestern Memorial Hospital,...
Determining if you'll never need treatment. It is feasible and safe to stop specialized follow-up of asymptomatic lower risk CLL?
Regular readers will have often heard that around 30% of those diagnosed with CLL never need...
Aussies, please consider enrolling in this study into the personal impact of CLL and help our world wide CLL/SLL community
Australians diagnosed with chronic lymphocytic leukaemia/small lymphocytic lymphoma (CLL/SLL),...
EHA 2022: Outcomes Following Treatment With a Covalent BTK and BCL2 Inhibitor
https://cllsociety.org/2022/08/eha-2022-outcomes-following-treatment-with-a-covalent-btk-and-bcl2-in
Relative risk for secondary bone marrow cancer within 5 years after initial CLL chemoimmunotherapy treatment (typically BR or FCR)
In countries where targeted therapies ('brutinibs, venetoclax, obinutuzumab/rituximab) are now...
Related Posts
CLL INFORMATION - A developing reliable and current international list of CLL Information & Resources.
Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with CLL
Ibrutinib Slow but steady foreward movement.- Leukaemia Care Updated Patient Information - Richter's Syndrome in Chronic Lymphocytic Leukaemia
- Why Is the Immunoglobulin Heavy Chain Gene Mutation Status a Prognostic Indicator in CLL? - Dr Keating
